PA1, also known as protein activator 1, is intricately involved in the regulation of chromatin remodeling and gene expression. It functions primarily by modulating the activity of specific histone acetyltransferases (HATs), which play a critical role in the modification of chromatin structure. This modification allows for the dynamic regulation of gene accessibility for transcriptional machinery, thereby controlling gene expression levels crucial for various cellular processes such as differentiation, proliferation, and response to external stimuli. PA1 is part of a larger complex involved in the acetylation of histone proteins, a post-translational modification that serves to relax the tightly wound chromatin, making specific genes more accessible for transcription. Through its regulation of HAT activity, PA1 directly influences the acetylation pattern of histones, impacting gene expression profiles across different cellular conditions and contributing to the cellular adaptation to environmental changes.
The activation of PA1 involves several regulatory mechanisms that ensure its activity is tightly controlled and contextually appropriate. Firstly, the transcription of the PA1 gene itself can be regulated by upstream signaling pathways that respond to various intracellular and extracellular cues, adjusting PA1 expression levels according to the cellular needs. This transcriptional regulation is crucial as it provides the primary means of controlling PA1 availability within the cell. Secondly, once synthesized, PA1 may undergo post-translational modifications that can alter its interaction affinity with HATs or other components of the chromatin remodeling complexes. These modifications, such as phosphorylation or ubiquitination, can influence PA1's activation state, stability, and its ability to effectively participate in the regulation of gene expression. Furthermore, the interaction of PA1 with other protein partners within the chromatin remodeling complexes is also a critical aspect of its regulation. These interactions not only facilitate the proper localization of PA1 within the nucleus but also ensure that its activity is exerted precisely where and when it is needed, particularly in the context of chromatin accessibility and gene transcription processes. Through these layers of regulation, PA1 plays a vital role in modulating the structural dynamics of chromatin, thereby influencing the transcriptional landscape of the cell in response to various developmental and environmental conditions.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases cAMP levels, facilitating PKA activation. PKA can alter transcription factors that may regulate PA1 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator. SIRT1 activation can affect chromatin remodeling, thereby possibly influencing PA1 transcription. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Inositol triphosphate (IP3) receptor antagonist. It affects Ca2+ signaling which can indirectly modulate PA1 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase-4 (PDE4) inhibitor that stabilizes cAMP levels. By sustaining cAMP levels, it may indirectly enhance PKA-dependent regulation of PA1. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
CaMKII inhibitor. By affecting Ca2+ signaling, this inhibitor can influence pathways that might utilize PA1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor. By modulating the Akt pathway, it can shift the signaling milieu to processes where PA1 plays a role. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor. Affects cellular energy status and protein translation, indirectly affecting the pathways where PA1 functions. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
PP2A inhibitor. By inhibiting PP2A, it may modulate phosphorylation events that can indirectly influence PA1 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. By inhibiting JNK, it might channel cellular activity toward pathways where PA1 is active. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. Modulates the Akt pathway, possibly redirecting cellular activity to pathways where PA1 functions. | ||||||